Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Remke

Showing results (101-110 of 184) with videos related to

Pageof 19
Sort By:
Radiation Oncology (London, England)|January 29, 2025
Alpha/beta values in pediatric medulloblastoma: implications for tailored approaches in radiation oncologyDanny Jazmati, Dennis Sohn, Juliane Hörner-Rieber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 10, 2010
TP53 mutation is frequently associated with CTNNB1 mutation or MYCN amplification and is compatible with long-term survival in medulloblastomaElke Pfaff, Marc Remke, Dominik Sturm, et al.
Cancer Cell|February 14, 2018
Programming of Schwann Cells by Lats1/2-TAZ/YAP Signaling Drives Malignant Peripheral Nerve Sheath TumorigenesisLai Man Natalie Wu, Yaqi Deng, Jincheng Wang, et al.
Cell Death & Disease|December 6, 2023
Co-targeting HSP90 alpha and CDK7 overcomes resistance against HSP90 inhibitors in BCR-ABL1+ leukemia cellsMelina Vogt, Niklas Dienstbier, Julian Schliehe-Diecks, et al.
Acta Neuropathologica|April 22, 2010
Focal genomic amplification at 19q13.42 comprises a powerful diagnostic marker for embryonal tumors with ependymoblastic rosettesAndrey Korshunov, Marc Remke, Marco Gessi, et al.
Biorxiv : the Preprint Server for Biology|May 18, 2026
<i>hTERT</i> Expression, Regulation, and Prognostic Significance in Pediatric MedulloblastomaRyuma Tanaka, Banlanjo Umaru, Matthew Sobo, et al.
Nature Communications|April 15, 2020
Modeling germline mutations in pineoblastoma uncovers lysosome disruption-based therapyPhilip E D Chung, Deena M A Gendoo, Ronak Ghanbari-Azarnier, et al.
Acta Neuropathologica|December 3, 2011
MicroRNA-182 promotes leptomeningeal spread of non-sonic hedgehog-medulloblastomaAlfa H C Bai, Till Milde, Marc Remke, et al.
The American Journal of Pathology|September 19, 2012
The RNA-binding protein Musashi1 affects medulloblastoma growth via a network of cancer-related genes and is an indicator of poor prognosisDat T Vo, Dharmalingam Subramaniam, Marc Remke, et al.
Acta Neuropathologica|September 1, 2023
Integrative multi-omics reveals two biologically distinct groups of pilocytic astrocytomaDaniel Picard, Jörg Felsberg, Maike Langini, et al.
Pageof 19

Showing results (101-110 of 184) with videos related to

Sort By:
Pageof 19
Radiation Oncology (London, England)|January 29, 2025
Alpha/beta values in pediatric medulloblastoma: implications for tailored approaches in radiation oncologyDanny Jazmati, Dennis Sohn, Juliane Hörner-Rieber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 10, 2010
TP53 mutation is frequently associated with CTNNB1 mutation or MYCN amplification and is compatible with long-term survival in medulloblastomaElke Pfaff, Marc Remke, Dominik Sturm, et al.
Cancer Cell|February 14, 2018
Programming of Schwann Cells by Lats1/2-TAZ/YAP Signaling Drives Malignant Peripheral Nerve Sheath TumorigenesisLai Man Natalie Wu, Yaqi Deng, Jincheng Wang, et al.
Cell Death & Disease|December 6, 2023
Co-targeting HSP90 alpha and CDK7 overcomes resistance against HSP90 inhibitors in BCR-ABL1+ leukemia cellsMelina Vogt, Niklas Dienstbier, Julian Schliehe-Diecks, et al.
Acta Neuropathologica|April 22, 2010
Focal genomic amplification at 19q13.42 comprises a powerful diagnostic marker for embryonal tumors with ependymoblastic rosettesAndrey Korshunov, Marc Remke, Marco Gessi, et al.
Biorxiv : the Preprint Server for Biology|May 18, 2026
<i>hTERT</i> Expression, Regulation, and Prognostic Significance in Pediatric MedulloblastomaRyuma Tanaka, Banlanjo Umaru, Matthew Sobo, et al.
Nature Communications|April 15, 2020
Modeling germline mutations in pineoblastoma uncovers lysosome disruption-based therapyPhilip E D Chung, Deena M A Gendoo, Ronak Ghanbari-Azarnier, et al.
Acta Neuropathologica|December 3, 2011
MicroRNA-182 promotes leptomeningeal spread of non-sonic hedgehog-medulloblastomaAlfa H C Bai, Till Milde, Marc Remke, et al.
The American Journal of Pathology|September 19, 2012
The RNA-binding protein Musashi1 affects medulloblastoma growth via a network of cancer-related genes and is an indicator of poor prognosisDat T Vo, Dharmalingam Subramaniam, Marc Remke, et al.
Acta Neuropathologica|September 1, 2023
Integrative multi-omics reveals two biologically distinct groups of pilocytic astrocytomaDaniel Picard, Jörg Felsberg, Maike Langini, et al.
Pageof 19